Studies prove that the postpartum administration of a single dose of an anti-D immune globulin, such as HyperRHO® S/D (RhO[D] immune globulin [human]), to susceptible Rh-negative women within 72 hours of delivery reduces the alloimmunization rate by 90%.1
Location: Brooklyn, New York
Incident: After months of trying to get pregnant, Kim was expecting her first child and approaching 28 weeks' gestation. She went to her OB/GYN frequently, and, during a recent visit, Kim's doctor drew blood. It was discovered that she was Rh negative. Although Kim hadn't read many books on pregnancy, she knew that HDN was potentially serious, and she was anxious to seek preventative measures.
Next Steps: Further testing revealed that the father was Rh positive, and her doctor explained the dangers of HDN. The following factors made it clear to Kim's physician that administering a
RhO immune globulin, such as HyperRHO S/D, was a necessary step in preventing HDN:
- The mother had Rh-negative blood
- The mother had not been sensitized to the Rh-positive blood cells
- The father had Rh-positive blood
Outcome: The doctor gave Kim her first dose of HyperRHO S/D Full Dose at 28 weeks' gestation. Once Kim had delivered her baby, she received a second dose of HyperRHO S/D Full Dose within 72 hours. Both mom and baby are fine, and now Kim may have confidence with future pregnancies because she has the protection that comes with receiving HyperRHO S/D.